Skip to content
AnalystLens

CME GROUP INC. Quarterly Report for Q2 Ended Jun 30, 2024

Filing Date
Filed August 5, 2024
Period End
June 30, 2024
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Feb ’20Feb ’20
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 10-Q filed August 5, 2024. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. reported strong financial performance for the second quarter and first half of 2024, with total revenues increasing by 13%a and 8% respectively year-over-year.

This growth was primarily driven by a 12%b increase in clearing and transaction fees in the second quarter and 6% in the first half, supported by a 15% rise in total contract volume in Q2 and 5% in H1. The company also saw a 7% increase in market data and information services revenue. Net income grew by a healthy 14% in the second quarter and 5% in the first half, demonstrating effective cost management as total expenses only increased by 2% and 1% respectively.

Diluted earnings per share also showed positive growth. Despite a decrease in investment income due to lower reinvestment balances from performance bonds, overall financial health remains robust, supported by strong operating cash flows and ample liquidity from its credit facilities. The company continues to manage its debt effectively and maintains investment-grade credit ratings.

Key Highlights

  1. Total revenues increased significantly, up 13% to $1.53 billion for Q2 2024 and 8% to $3.02 billion for the first six months of 2024.
  2. Clearing and transaction fees, the primary revenue driver, saw a 12% increase in Q2 and 6% in H1, propelled by a substantial rise in contract volumes.
  3. Contract volume experienced strong growth, with a 15% increase in Q2 and 5% in H1, indicating increased market activity and client engagement.
  4. Net income grew by 14% in Q2 to $883.2 million and 5% in H1 to $1.74 billion, reflecting efficient operations.
  5. Diluted earnings per common share rose to $2.42 in Q2 and $4.77 for the first six months, outpacing the prior year.
  6. Market data and information services revenue showed consistent growth, up 7% for both Q2 and H1, adding to revenue diversification.
  7. Operating expenses were well-managed, with a modest increase of 2% in Q2 and 1% in H1, contributing to improved operating margins.

Financial Statements

Q2 FY2024 against Q2 FY2023

Line itemQ2 FY2024Q2 FY2023Change
Revenue$1.53B$1.36B+12.7%
Operating Expenses$531.90M$521.60M+2.0%
Operating Income$1.00B$838.60M+19.3%
Net Income$883.20M$777.60M+13.6%
EPS (Basic)$2.43$2.14+13.6%
EPS (Diluted)$2.42$2.14+13.1%
Shares Outstanding (Basic)359.33M358.94M+0.1%
Shares Outstanding (Diluted)359.87M359.43M+0.1%

Frequently Asked Questions

  1. What drove the increase in revenue for CME Group?

    The primary driver for the revenue increase was a significant rise in clearing and transaction fees, which was fueled by a substantial increase in total contract volume across various asset classes, including interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals. Additionally, revenue from market data and information services also contributed positively.

  2. How did CME Group manage its expenses relative to revenue growth?

    CME Group demonstrated effective cost management. While revenues saw robust growth, total expenses increased at a much slower pace (2% in Q2 and 1% in H1). This controlled expense growth, particularly in areas like technology and compensation, contributed to an expansion of operating margins and a healthy increase in net income.

  3. What is the outlook for contract volumes and trading activity?

    The filing indicates that market uncertainty, stemming from factors like Federal Reserve interest rate policy, geopolitical events, and weather conditions, contributed to higher trading volumes. The company experienced a significant increase in contract volume in Q2 and a more moderate increase in H1, suggesting continued active markets. The trend points towards sustained or potentially increasing trading activity, driven by ongoing market volatility and economic factors.

  4. What is CME Group's liquidity position and debt management strategy?

    CME Group maintains a strong liquidity position with significant cash and cash equivalents, supplemented by substantial unused capacity under its revolving credit facilities. The company's debt levels have decreased, and it continues to manage its debt maturities effectively, maintaining investment-grade credit ratings. The company relies on dividends from its subsidiaries to fund its operations and shareholder distributions.